Shaping the Future of Heart Health- An Analysis of the Indian Cardiology Market
Indian cardiology market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2024-2031). The key factors influencing the market growth of Indian cardiology are increasing incidence of cardiovascular diseases, frequent technology updates in cardiovascular devices, reforms in the pricing and government policies which led to the availability of devices, entry of Indian manufacturers in the global markets, and enhanced investment in R&D and collaboration in manufacturing.
Browse the full report description of “Indian Cardiology Market Size, Share & Trends Analysis Report by Cardiology Device Types (Cardiovascular Stents, Cardiovascular Catheters, Cardiac Rhythm Management Devices, and Cardiovascular Assistive Devices), by Drugs Types (Antithrombotic Drugs, Antidyslipidemic Drugs, Antihypertensive Drugs, and Anti-Stroke Drugs) by Surgery Types (Coronary Artery Bypass Grafting, Transmyocardial Laser Revascularization, Heart Valve Repair, Cardiac Resynchronization Therapy (CRT), Aneurysm Repair, and Heart Transplant) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/indian-cardiology-market-size
Recent Developments
- In April 2023, the Indian Institute of Technology Madras introduced ARTSENS, a noninvasive diagnostic tool for blood vessel evaluation. It can detect cardiovascular diseases at an early stage, and the device is easy to use, enabling simple check-ups from laymen.
- In September 2022, GE Healthcare introduced the Optima IGS 320 Cath Lab, an AI-powered product, to the Indian market. This is an interventional imaging software that enhances cardiac care by providing detailed, non-invasive treatments and automating the AutoRight function to lighten the load of an interventionalist while helping deliver more purposeful care.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Cardiology Device Type
o By Drugs Type
o By Surgery Type
• Competitive Landscape- Boston Scientific Corp., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., and Medtronic PLC among others.
Key questions addressed by the report.
- What is the market growth rate?
- Which segment dominates the market in the base year?
- Which segment will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Indian Cardiology Market Report Segment
By Cardiology Device Type
- Cardiovascular Stents
- Cardiovascular Catheters
- Cardiac Rhythm Management Devices
- Cardiovascular Assistive Devices
By Drugs Type
- Antithrombotic Drugs
- Antidyslipidemic Drugs
- Antihypertensive Drugs
- Anti-Stroke Drugs
By Surgery Types
- Coronary Artery Bypass Grafting
- Transmyocardial Laser Revascularization
- Heart Valve Repair
- Cardiac Resynchronization Therapy (CRT)
- Aneurysm Repair
- Heart Transplant
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-cardiology-market-size